Britain's Most Admired Companies 2013: Health and household

It's the second year for the BMAC's health and household sector - but is big pharma still as big as it was in 2012?

by
Last Updated: 04 Dec 2013

All change at the top, as BMAC debutant Abcam takes the sector prize. A great result for the Cambridge-based supplier of monoclonal antibodies - among other things - to genetic researchers across the globe. GlaxoSmithKline has slipped, but only by one place, to second. Bribery accusations by the Chinese government appear to have done little reputational damage so far. Generic drugs maker Shire is up two places, while Cilit Bang-to-Durex giant Reckitt Benckiser is rumoured to be considering selling off its pharma arm entirely. Sales of its big heroin addiction drug, Suboxone, have been hit by cheaper rivals. Fifth-placed Smith & Nephew has a new chairman in industry veteran Roberto Quarta, and posted Q3 sales up 5% to $1.03bn.

- Go to the BMAC homepage

Find this article useful?

Get more great articles like this in your inbox every lunchtime

How redundancies affect culture

There are ways of preventing 'survivor syndrome' derailing your recovery.

What they don't tell you about inclusive leadership

Briefing: Frances Frei was hired to fix Uber’s ‘bro culture’. Here’s her lesson for where...

Should you downsize the office?

Many businesses are preparing for a 'hybrid' workplace.

How to make your team more accountable

‘Do as I do’ works a lot better than ‘do as I say’.

Black talent isn’t hard to find: It’s just you

If you want to attract the widest range of applicants, you need to think about...

Drowning in data: The case for the business generalist

Expertise and algorithms are overrated. Try using your brain, says this Harvard academic.